Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
For information about UK patent expirations
— Pharmacist, UK
To plan ahead for inventory purposes
— Pharmacy purchaser, USA
To find patent expiration dates of small molecules in the next ten years
— Pharmaceutical product development, India
To find all manufacturers of a drug with active DMFs
— CEO, specialty pharmaceutical firm, USA
To get information about drug synthesis
— Chemical research, Spain
Generated: May 23, 2017
| Patents: | 9 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 8,431,155 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 9,192,576 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 7,888,310 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 9,522,117 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 8,137,992 | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Updates on patents, new and expired; market watch on IP activities
— Formulation development scientist, India
For information on medications and their innovator companies, as well as their patency profiles
— Pharmacist, Nigeria
To identify drugs going off patent in the next five years
— Pharmaceutical product development coordinator, Indonesia
To get information on pharmaceutical patents
— Business development, China
For patent and exclusivity due dligience
— Pharma investment firm, USA
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
